581 related articles for article (PubMed ID: 34710063)
21. Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines.
Hromić-Jahjefendić A; Lundstrom K; Adilović M; Aljabali AAA; Tambuwala MM; Serrano-Aroca Á; Uversky VN
Autoimmun Rev; 2024 Mar; 23(3):103508. PubMed ID: 38160960
[TBL] [Abstract][Full Text] [Related]
22. SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS.
Juanes-Velasco P; Landeira-Viñuela A; García-Vaquero ML; Lecrevisse Q; Herrero R; Ferruelo A; Góngora R; Corrales F; Rivas JL; Lorente JA; Hernández ÁP; Fuentes M
Front Immunol; 2022; 13():732197. PubMed ID: 35154090
[TBL] [Abstract][Full Text] [Related]
23. COVID-19 and autoimmune diseases: is there a connection?
Votto M; Castagnoli R; Marseglia GL; Licari A; Brambilla I
Curr Opin Allergy Clin Immunol; 2023 Apr; 23(2):185-192. PubMed ID: 36728317
[TBL] [Abstract][Full Text] [Related]
24. Case Report: Systemic Sclerosis After Covid-19 Infection.
Fineschi S
Front Immunol; 2021; 12():686699. PubMed ID: 34262566
[TBL] [Abstract][Full Text] [Related]
25. An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19.
Wang JY; Zhang W; Roehrl MW; Roehrl VB; Roehrl MH
J Autoimmun; 2021 Jun; 120():102644. PubMed ID: 33971585
[TBL] [Abstract][Full Text] [Related]
26. CCR2 Signaling Restricts SARS-CoV-2 Infection.
Vanderheiden A; Thomas J; Soung AL; Davis-Gardner ME; Floyd K; Jin F; Cowan DA; Pellegrini K; Shi PY; Grakoui A; Klein RS; Bosinger SE; Kohlmeier JE; Menachery VD; Suthar MS
mBio; 2021 Dec; 12(6):e0274921. PubMed ID: 34749524
[TBL] [Abstract][Full Text] [Related]
27. Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection.
Vahabi M; Ghazanfari T; Sepehrnia S
Int Immunopharmacol; 2022 Nov; 112():109183. PubMed ID: 36182877
[TBL] [Abstract][Full Text] [Related]
28. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
Weindel CG; Richey LJ; Bolland S; Mehta AJ; Kearney JF; Huber BT
Autophagy; 2015; 11(7):1010-24. PubMed ID: 26120731
[TBL] [Abstract][Full Text] [Related]
29. Autoantibodies and autoimmune disorders in SARS-CoV-2 infection: pathogenicity and immune regulation.
Darmarajan T; Paudel KR; Candasamy M; Chellian J; Madheswaran T; Sakthivel LP; Goh BH; Gupta PK; Jha NK; Devkota HP; Gupta G; Gulati M; Singh SK; Hansbro PM; Oliver BGG; Dua K; Chellappan DK
Environ Sci Pollut Res Int; 2022 Aug; 29(36):54072-54087. PubMed ID: 35657545
[TBL] [Abstract][Full Text] [Related]
30. Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD).
Gagiannis D; Steinestel J; Hackenbroch C; Schreiner B; Hannemann M; Bloch W; Umathum VG; Gebauer N; Rother C; Stahl M; Witte HM; Steinestel K
Front Immunol; 2020; 11():587517. PubMed ID: 33123171
[TBL] [Abstract][Full Text] [Related]
31. Case report of COVID-19 in an elderly patient: could SARS-CoV2 trigger myositis?
Sacchi MC; Tamiazzo S; Lauritano EC; Bonometti R
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11960-11963. PubMed ID: 33275270
[TBL] [Abstract][Full Text] [Related]
32. Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals.
Lingel H; Meltendorf S; Billing U; Thurm C; Vogel K; Majer C; Prätsch F; Roggenbuck D; Heuft HG; Hachenberg T; Feist E; Reinhold D; Brunner-Weinzierl MC
J Autoimmun; 2021 Aug; 122():102682. PubMed ID: 34214763
[TBL] [Abstract][Full Text] [Related]
33. The mosaic of autoimmunity - A taste for more. The 12th international congress of autoimmunity 2021 (AUTO12) virtual.
Mahroum N; Zoubi M; Lavine N; Ohayon A; Amital H; Shoenfeld Y
Autoimmun Rev; 2021 Nov; 20(11):102945. PubMed ID: 34509655
[TBL] [Abstract][Full Text] [Related]
34. Human genetics of SARS-CoV-2 infection and critical COVID-19.
Mogensen TH
Clin Microbiol Infect; 2022 Nov; 28(11):1417-1421. PubMed ID: 35218979
[TBL] [Abstract][Full Text] [Related]
35. Autoimmunity is a hallmark of post-COVID syndrome.
Rojas M; Rodríguez Y; Acosta-Ampudia Y; Monsalve DM; Zhu C; Li QZ; Ramírez-Santana C; Anaya JM
J Transl Med; 2022 Mar; 20(1):129. PubMed ID: 35296346
[TBL] [Abstract][Full Text] [Related]
36. Autoimmunity and Immunodeficiency in Severe SARS-CoV-2 Infection and Prolonged COVID-19.
Garmendia JV; García AH; De Sanctis CV; Hajdúch M; De Sanctis JB
Curr Issues Mol Biol; 2022 Dec; 45(1):33-50. PubMed ID: 36661489
[TBL] [Abstract][Full Text] [Related]
37. Autoimmunity and SARS-CoV-2 infection: Unraveling the link in neurological disorders.
Latorre D
Eur J Immunol; 2022 Oct; 52(10):1561-1571. PubMed ID: 35833748
[TBL] [Abstract][Full Text] [Related]
38. Adaptive Immunity and the Risk of Autoreactivity in COVID-19.
Moody R; Wilson K; Flanagan KL; Jaworowski A; Plebanski M
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445670
[TBL] [Abstract][Full Text] [Related]
39. Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity.
Vono M; Huttner A; Lemeille S; Martinez-Murillo P; Meyer B; Baggio S; Sharma S; Thiriard A; Marchant A; Godeke GJ; Reusken C; Alvarez C; Perez-Rodriguez F; Eckerle I; Kaiser L; Loevy N; Eberhardt CS; Blanchard-Rohner G; Siegrist CA; Didierlaurent AM
Cell Rep; 2021 Oct; 37(1):109773. PubMed ID: 34587479
[TBL] [Abstract][Full Text] [Related]
40. Patients with severe COVID-19 do not have elevated autoantibodies against common diagnostic autoantigens.
Ulndreaj A; Wang M; Misaghian S; Paone L; Sigal GB; Stengelin M; Campbell C; Van Nynatten LR; Soosaipillai A; Ghorbani A; Mathew A; Fraser DD; Diamandis EP; Prassas I
Clin Chem Lab Med; 2022 Jun; 60(7):1116-1123. PubMed ID: 35475723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
